340B REPORT SPONSOR SPOTLIGHT

RxParadigm

Q: Tell us some interesting details about your company’s history.

RxParadigm was built to stay ahead of the curve in healthcare’s most complex arenas. From our inception, we’ve focused on developing technology that simplifies drug pricing and compliance for manufacturers, pharmacies, and covered entities. By anticipating regulatory shifts and industry demands, we’ve positioned ourselves as a trusted partner for navigating change.

That commitment is especially critical as January 1, 2026 approaches. With the launch of the Maximum Fair Price mandate and the 340B Rebate Model Pilot, the industry faces new operational and financial pressures. Our flagship platform, Tungsten+ PLUS™, is already connected to CMS’s Medicare Transaction Facilitator (MTF) as a certified Third-Party Support Entity (TPSE). Designed as a single, comprehensive solution, Tungsten+ PLUS™ delivers duplicate discount prevention, IRA Maximum Fair Price effectuation, and administration of the 340B Rebate Model Pilot—empowering stakeholders to adapt seamlessly to the future of healthcare.

Q: Provide some fun facts about your company:

  • Based in Claymont, Delaware—where big healthcare solutions are built in a small town.
  • Tungsten+ PLUS™ powers 3 major programs with 1 streamlined platform.
  • Our brand colors—yellow and black—symbolize energy, clarity, and strength.
  • Our leadership team blends experience from hospitals, pharmacies, pharma, TPAs, tech, and PBMs for a 360° perspective.
  • Certified by CMS as an MTF Trusted Technology and Compliance Partner.
  • Proudly recognized as a Minority-Owned Business Enterprise.

Q: What makes your company unique in the 340B space?

RxParadigm is uniquely positioned to help stakeholders navigate the rapidly evolving 340B landscape. Our flagship platform, Tungsten+ PLUS™, was purpose-built to adapt to regulatory change and already incorporates the capabilities needed to support CMS’s new requirements under the Maximum Fair Price and 340B Rebate Model. With a blend of technical infrastructure and compliance expertise, we focus on making these complex transitions as seamless as possible for covered entities, pharmacies, and manufacturers alike.

Q: What about your company’s work are you most proud of?

We are most proud of RxParadigm’s unwavering commitment to our core mission: simplifying the drug supply chain. Despite competing pressures from across the healthcare ecosystem, we have stayed the course, developing solutions that bring clarity and efficiency to the 340B program. The strongest testimony to this effort is our Tungsten+ PLUS™ platform, designed to evolve with the industry and support the government’s new requirements for Maximum Fair Price and the 340B Rebate Model Pilot, while continuing to prevent Medicaid duplicate discounts. This proactive, future-focused approach underscores our dedication to helping stakeholders navigate complexity with confidence and clarity.

Learn more about RxParadigm or for questions email: carlo.cioffi@rxparadigm.com.

340B Report
+ posts

Read more 340B Expert Tips

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live

Sliding Sidebar

Link to spotlight on Sean Hall of Visante

Article Archives